AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Recruiting
Observational Study
Gastric Cancer
Image
Pathology
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Chinese Academy of Sciences · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study seeks to develop a deep-learning-based intelligent predictive model for the efficacy of neoadjuvant chemotherapy in gastric cancer patients. By utilizing the patients' CT imaging data, biopsy pathology images, and clinical information, the intelligent model will predict the post-neoadjuvant chemotherapy efficacy and prognosis, offering assistance in personalized treatment decisions for …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18 years or older;
* Pathologically diagnosed with advanced gastric cancer in accordance with the American AJCC's TNM staging standards;
* Have not undergone any systematic anti-cancer treatments before neoadjuvant chemotherapy and have not had surgery for local progressio…
Contacts